BDBM560831 (R)-2-((1r,4R)-4-(6-fluoroquinolin-4-yl)cyclohexyl)-N-(4-(pentafluoro-lambda6-sulfanyl)phenyl)propanamide::US11389445, Compound 2

SMILES C[C@H]([C@H]1CC[C@@H](CC1)c1ccnc2ccc(F)cc12)C(=O)Nc1ccc(cc1)S(F)(F)(F)(F)F

InChI Key InChIKey=WXYPXPJEQWVIBC-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 560831   

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM560831(US11389445, Compound 2 | (R)-2-((1r,4R)-4-(6-fluor...)
Affinity DataIC50: 600nMAssay Description:The experimental principle is summarized as follows: IDO expression is low in Hela cells under no induction, but a certain concentration of IFN-γ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2022
Entry Details
US Patent